期刊文献+

扶正化瘀片与多烯磷脂酰胆碱治疗非酒精性脂肪肝的疗效比较 被引量:1

Comparison of the Therapeutic Effect of FuzhengHuayu Tablet and Polyene Phosphatidylcholine on Nonalcoholic Fatty Liver
下载PDF
导出
摘要 目的:探讨扶正化瘀片与多烯磷脂酰胆碱治疗非酒精性脂肪肝的疗效。方法:本次研究中所纳入的研究对象为我院医治的120例非酒精性脂肪肝患者,选取的时间段为2019年1月至2019年12月,按不同的治疗方式分为对照组(n = 60)与观察组(n = 60),对照组采用多烯磷脂酰胆碱治疗,观察组采用扶正化瘀片治疗。观察两组患者肝功能变化情况。结果:两组患者治疗前ALT、AST、TBil无明显差异(P 】0.05),治疗3周、治疗12周后观察组患者GGT指标均明显低于对照组患者(P 0.05),但治疗后对照组实验组比较无统计学差异(P 0.05);两组治疗后比较无明显差异(P 【0.05)。结论:采用扶正化瘀片治疗非酒精性脂肪肝,能明显改善患者的肝功能指标及肝脏组织学评分,疗效确切,值得应用。 Objective: To explore the therapeutic effect of FuzhengHuayu tablet and polyene phosphatidylcholine on nonalcoholic fatty liver. Methods: 120 cases of nonalcoholic fatty liver treated in our hospital were included in this study. The selected period was from January 2019 to December 2019. According to different treatment methods, they were divided into the control group (n = 60) and the observation group (n = 60). The control group was treated with polyene phosphatidylcholine, and the observation group was treated with FuzhengHuayu tablet. The changes of liver function in the two groups were observed. Results: There was no significant difference in alt, AST and TBIL between the two groups before treatment (P >0.05). GGT indexes of observation group were significantly lower than those of control group after 3 weeks and 12 weeks of treatment (P 0.05), but there was no statistical difference between the two groups (P 0.05);there was no significant difference between the two groups after treatment (P
出处 《临床医学进展》 2021年第2期439-443,共5页 Advances in Clinical Medicine
  • 相关文献

参考文献13

二级参考文献140

共引文献110

同被引文献9

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部